Global Antifungal Drugs Market report offers the latest industry trends,
technological alteration and forecast data. A deep-dive view of Antifungal
Drugs industry based on its size, growth, development plans, and opportunities
is offered by this report. The forecast information, SWOT analysis, Antifungal
Drugs barriers, and feasibility study are the vital aspects evaluated in this
report.
Global Antifungal
Drugs Market is anticipated to reach USD 12.6 billion by 2025. Anti-fungal
drugs, as the name suggests, are used to cure fungal infections. Common fungal
infections such as ringworm, fungal nail infection, and vaginal infection
typically occur on the external surface of the body, although specific fungal
invasive infections occur in an internal body organs such as brain and lungs.
The factors that
propel the growth of the Antifungal Drugs Market include increasing occurrence
of fungal infections across the globe, increasing consciousness, and ongoing
research and development in anti-fungal drugs. On the other hand, there are
factors that may hamper the growth of the market including occurrence of
counterfeit drugs and resistance towards antifungal drugs.
Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/antifungal-drugs-market/request-sample
Main features
of the report:
·
To provide detailed analysis of the market
structure along with forecast of the various segments and sub-segments of the
global Antifungal Drugs Market.
·
A complete backdrop analysis, which includes an
assessment of the parent market
·
Important changes in market dynamics
·
Market segmentation up to the second or third
level
·
To provide country level analysis of the market
for segment by application, product type and sub-segments.
·
To provide strategic profiling of key players in
the market, comprehensively analyzing their core competencies, and drawing a
competitive landscape for the market.
·
Track and analyze competitive developments such
as joint ventures, strategic alliances, mergers and acquisitions, new product
developments, and research and developments in the global Antifungal Drugs
Market.
·
Emerging niche segments and regional markets
·
An objective assessment of the trajectory of the
industry.
The antifungal
agents presently available for the treatment of complete fungal infections are:
amphotericin B and lipid formulations of amphotericin B,
azoles,5-fluorocytosine, ketoconazole, miconazole, fluconazole and
itraconazole. Antifungal Drugs Industry is anticipated to grow at a significant
CAGR in the upcoming period as the scope, product types, and its applications
are increasing across the globe. The industry may be explored by drug type,
dosage form, infection type, therapeutic indications and geography.
Antifungal Drugs
Market may be explored by drug type as Azoles may further include (Thiazoles,
Voricanazole, Imidazole’s, and Others), Echinocandins may further include
(Anidulafungin, Micafungin, Caspofungin, and Others), Allylamines may further
include (Naftifine, Terbinafine, Butenafine, and Others), and Polyenes may
further include (Amphotericin B, Candicidin, Natamycin, Hamycin, and Others).
The “Azoles” segment led the Antifungal Drugs Industry in 2015 and is
anticipated to maintain its dominance by 2025. The key factor that could be
attributed to the growth may include composition of important agents such as
Vfend, Diflucan, and Noxafil, and extensive usage in the treatment of
candidemia, blastomycosis, systemic candidiasis and ocular fungal infections.
The dosage form that
could be explored in the Antifungal Drugs Industry include Drugs, Ointments,
Powders, and Others. The industry could be explored based on infection type as
Systemic Antifungal Infections, and superficial Antifungal Infections. The
market may be analyzed by therapeutic indications as Dermatophytosis,
Aspergillosis, Candidiasis, and Others. The “Dermatophytosis” segment led the
market in 2015 and is anticipated to maintain its dominance by 2025. The
factors that could be attributed to the growth include increasing occurrence of
skin infections in kids, and rise in the incidence of opportunistic fungal
infections that will eventually surge the Dermatophytosis segment in the
forecast period.
North America
accounted for the major share of the Antifungal Drugs Market Size in 2015 and
will continue to lead in the forecast period. The factors that could be
attributed to the growth include high patient consciousness levels, and R&D
strength pertaining to new drug development.
Some of the key
players that fuel the growth of the Antifungal Drugs Industry comprise
Sigma-Aldrich Corporation, Astellas Pharma, Inc., Agilent Technologies, Inc.,
Inc. (a subsidiary of Danaher Corporation), Beckman Coulter, Kramer
Laboratories, Valeant Pharmaceuticals International, Inc., Tecan Group, and
Basilea Pharmaceutical Ltd. The leading companies are taking up partnerships,
mergers and acquisitions, and joint ventures in order to boost the inorganic
growth of the industry.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment